Table of Contents
1. TLR Agonists - by Receptor Subtype
- TLR3 Agonists
- TLR4 Agonists
- TLR7 Agonists
- TLR7/8 Agonists
- TLR8 Agonists
- TLR9 Agonists
- TLR Agonists Unspecified
2. TLR Agonists - by Therapeutic Area
- Dermatology
- Gastrointestinal
- Infectious & toxicology
- Neurology & psychiatry
- Oncology
- Pulmonary & respiratory
- Rheumatoid & autoimmune
3. TLR Antagonists - by Receptor Subtype
- TLR4 Antagonists
- TLR7/(8)/9 Antagonists
4. TLR Antagonists - by Therapeutic Area
- Cardiovascular & acute care
- Gastrointestinal
- Rheumatoid & autoimmune
5. TLR Adjuvants by Receptor Subtype
- TLR3 Adjuvants
- TLR4 Adjuvants
- TLR7/8/9 Adjuvants
- TLR9 Adjuvants
6. TLR-Adjuvanted Vaccines - by Receptor Subtype
- Vaccines adjuvanted with TLR3 agonist
- Vaccines adjuvanted with TLR4 agonist
- Vaccines adjuvanted with TLR5 agonist
- Vaccines adjuvanted with TLR9 agonist
7. TLR-Adjuvanted Vaccines - by Therapeutic Area
- Prophylactic TLR-Adjuvanted Vaccines in Infectious Diseases
- Therapeutic TLR4-Adjuvanted Vaccines in Oncology
- Therapeutic TLR4-Adjuvanted Vaccines in Pulmonary & Respiratory Diseases
- Therapeutic TLR9-Adjuvanted Vaccines in Infectious Diseases
- Therapeutic TLR9-Adjuvanted Vaccines in Oncology
- Therapeutic TLR9-Adjuvanted Vaccines in Pulmonary & Respiratory Diseases
8. Corporate TLR Agonist & Antagonist R&D Portfolios
- 3M Drug Delivery Services
- Allergy Therapeutics
- Ampligen
- Anadys Pharmaceuticals
- Cytos Biotechnology
- Dynavax Technologies
- GlaxoSmithKline
- Idera Pharmaceuticals
- Index Pharmaceuticals
- Innate Pharma
- Intercell
- Juvaris Biotherapeutics
- Meda
- Merck & Co.
- Merck Serono
- Multicell Technologies
- Novartis
- Nventa Biopharmaceuticals
- OM Pharma
- Pfizer
- Vaxart
- VaxInnate
- VentiRx
|
Related Report
|
View Cart
